McKesson Corporation (FRA:MCK)

Market Cap	86.35B +20.0%
Revenue (ttm)	329.92B +17.2%
Net Income	3.44B +59.0%
EPS	27.37 +66.2%
Shares Out	n/a
PE Ratio	25.12
Forward PE	20.37
Dividend	2.72 (0.39%)
Ex-Dividend Date	Dec 1, 2025

Volume	n/a
Average Volume	1
Open	683.60
Previous Close	684.60
Day's Range	683.60 - 683.60
52-Week Range	561.60 - 768.00
Beta	n/a
RSI	41.39
Earnings Date	Feb 4, 2026

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MCK

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD